Kontrol Technologies (NEO: KNR) is reportedly investigating a potential patent infringement on its BioCloud technology. The revelation was quietly included in an unrelated news release made by the company this morning.
The patent infringement is said to come from “certain competitors in the marketplace,” although the company did not name the offender specifically. Kontrol continued that it “will protect its patents and technology for the benefit of its shareholders.”
Kontrol currently holds two patents in relation to its BioCloud tech, while a third is said to be pending. The first was received in April, US patent No. 11,619,571, and pertains to a collection chamber for an air sample system. The company filed three patents in the US and one in Canada back in November 2020.
The company separately announced this morning it had been selected to provide emission and analytics solutions by a customer in the activated carbon market. The customer is an activated carbon supplier, whom specializes in filter media for water and wastewater treatment.
Kontrol Technologies last traded at $0.245 on the Neo.
Information for this briefing was found via Sedar and Kontrol Technologies. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.